Kevin O’Leary fired off a post on X earlier this month that was part confession, part humblebrag. It started with a cat swab and ended with millions in his pocket. In classic Mr. Wonderful fashion, he admitted he once wrote a $250,000 check—not because he loved the pitch, but because he wanted it to go away.
“A woman pitched me a cat DNA test… for $29,” he posted. “I laughed. I told her, ‘I can buy a new cat for five bucks.’ But she wouldn’t give up. So I wrote a $250K check just to get rid of her.”
The woman was Anna Skaya. The company? Basepaws. On the surface, it looked like a gimmick—genetic testing for your cat. But underneath the fluff was a serious play in DNA data collection. And O’Leary? He cashed out hard.
Don’t Miss:
- Inspired by Uber and Airbnb – Deloitte’s fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!
- The $1.3 Billion Startup Investment Boom: How This Company’s Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum
In the video clip attached to the X post, he explained that when Skaya first appeared on “Shark Tank” in 2019, she pitched her swab-and-send kit to help pet owners learn more about their cat’s genetics, health risks, and diet needs. O’Leary mocked the idea. “No …
Full story available on Benzinga.com
Kevin O’Leary fired off a post on X earlier this month that was part confession, part humblebrag. It started with a cat swab and ended with millions in his pocket. In classic Mr. Wonderful fashion, he admitted he once wrote a $250,000 check—not because he loved the pitch, but because he wanted it to go away.
“A woman pitched me a cat DNA test… for $29,” he posted. “I laughed. I told her, ‘I can buy a new cat for five bucks.’ But she wouldn’t give up. So I wrote a $250K check just to get rid of her.”
The woman was Anna Skaya. The company? Basepaws. On the surface, it looked like a gimmick—genetic testing for your cat. But underneath the fluff was a serious play in DNA data collection. And O’Leary? He cashed out hard.
Don’t Miss:
- Inspired by Uber and Airbnb – Deloitte’s fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!
- The $1.3 Billion Startup Investment Boom: How This Company’s Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum
In the video clip attached to the X post, he explained that when Skaya first appeared on “Shark Tank” in 2019, she pitched her swab-and-send kit to help pet owners learn more about their cat’s genetics, health risks, and diet needs. O’Leary mocked the idea. “No …
Full story available on Benzinga.com
Kevin O’Leary fired off a post on X earlier this month that was part confession, part humblebrag. It started with a cat swab and ended with millions in his pocket. In classic Mr. Wonderful fashion, he admitted he once wrote a $250,000 check—not because he loved the pitch, but because he wanted it to go away.
“A woman pitched me a cat DNA test… for $29,” he posted. “I laughed. I told her, ‘I can buy a new cat for five bucks.’ But she wouldn’t give up. So I wrote a $250K check just to get rid of her.”
The woman was Anna Skaya. The company? Basepaws. On the surface, it looked like a gimmick—genetic testing for your cat. But underneath the fluff was a serious play in DNA data collection. And O’Leary? He cashed out hard.
Don’t Miss:
Inspired by Uber and Airbnb – Deloitte’s fastest-growing software company is transforming 7 billion smartphones into income-generating assets – with $1,000 you can invest at just $0.26/share!
The $1.3 Billion Startup Investment Boom: How This Company’s Explosive Growth Is Opening Doors For Everyday Investors With A New $500 Minimum
In the video clip attached to the X post, he explained that when Skaya first appeared on “Shark Tank” in 2019, she pitched her swab-and-send kit to help pet owners learn more about their cat’s genetics, health risks, and diet needs. O’Leary mocked the idea. “No …Full story available on Benzinga.com Read MoreNews, news access, Startups Access, News, Benzinga News
